V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10009213 | 10004002 | 1.85 | 68 | Palliative (P) | 2017-07-13 | 2018-02-15 | Rituximab | N | N | 10366762 | RITUXIMAB |
| 10009214 | 10004065 | 1.66 | 122 | Curative (C) | 2018-12-01 | 2019-01-31 | TRASTUZUMAB | 99 | N | 10376164 | TRASTUZUMAB |
| 10009215 | 10004071 | 1.66 | null | Palliative (P) | 2018-02-08 | 2018-06-23 | Paclitaxel 7 day | null | Y | 10377105 | PACLITAXEL |
| 10009216 | 10004084 | null | 84.6 | Palliative (P) | 2020-01-27 | 2020-01-27 | CHOP R - 14 days | N | N | 10378293 | CHOP R |
| 10009217 | 10004160 | null | 59 | Palliative (P) | 2016-08-20 | 2016-08-27 | Oxaliplatin + Modified de Gramont | null | null | 10409034 | OXALIPLATIN + MDG |
| 10009218 | 10004175 | 1.68 | 71.2 | Palliative (P) | 2016-03-24 | 2016-07-12 | FLUOROURACIL + OXALIPLATIN | N | N | 10410582 | OXALIPLATIN + MDG |
| 10009219 | 10004177 | null | 75.8 | null | 2017-10-05 | 2017-12-28 | CHOP R - 21 days | N | N | 10410849 | CHOP R |
| 10009220 | 10004193 | 1.73 | 96 | Disease modification (D) | 2018-06-26 | 2019-01-31 | Oxaliplatin + Modified de Gramont | 2 | N | 10412008 | OXALIPLATIN + MDG |
| 10009221 | 10004299 | 1.77 | 61.4 | Adjuvant (A) | 2017-04-18 | 2017-04-25 | Oxaliplatin + Modified de Gramont | N | Y | 10430585 | OXALIPLATIN + MDG |
| 10009222 | 10004308 | null | 80.3 | Palliative (P) | 2016-03-07 | 2016-04-06 | CHOP R | N | N | 10431154 | CHOP R |
| 10009223 | 10004354 | 1.63 | 59.1 | Palliative (P) | 2016-11-22 | 2016-11-26 | Carboplatin + Etoposide IV 3 day | N | N | 10435336 | CARBOPLATIN + ETOPOSIDE |
| 10009224 | 10008474 | 1.67 | 98.3 | Palliative (P) | 2019-03-17 | 2019-09-03 | Azacitidine | 02 | N | 10440735 | AZACITIDINE |
| 10009225 | 10004442 | 1.74 | 62.3 | Disease modification (D) | 2019-04-12 | 2019-04-21 | Pemetrexed | N | N | 10443536 | CARBOPLATIN + VINORELBINE |
| 10009226 | 10007283 | null | 66.4 | Curative (C) | 2017-08-13 | 2017-08-16 | Temozolomide 200mg/m2 | N | N | 10443855 | TEMOZOLOMIDE |
| 10009227 | 10004457 | 1.8 | null | Curative (C) | 2017-12-21 | 2017-12-21 | Trial Unspecified | null | null | 10445140 | TRIAL |
| 10009228 | 10004473 | 1.55 | 91.8 | Palliative (P) | 2016-12-24 | 2017-03-05 | CARBOPLATIN + ETOPOSIDE | 02 | N | 10448196 | CARBOPLATIN + ETOPOSIDE |
| 10009229 | 10004500 | 1.7 | 83.5 | null | 2017-01-10 | 2017-01-24 | GemCarbo Days 1+8 | N | N | 10450803 | LENALIDOMIDE |
| 10009230 | 10004524 | 0 | null | Palliative (P) | 2017-03-06 | 2017-05-12 | Bevacizumab | 02 | N | 10453802 | LENALIDOMIDE |
| 10009231 | 10004543 | 1.75 | 70.3 | Palliative (P) | 2018-09-16 | 2018-10-04 | Pemetrexed | 2 | N | 10455095 | CVP R |
| 10009232 | 10007331 | 1.62 | 55.8 | Palliative (P) | 2019-05-05 | 2019-09-02 | BCG Intravesical | 02 | N | 10457575 | CARBOPLATIN + PEMETREXED |
| 10009233 | 10004566 | 1.65 | 55 | Palliative (P) | 2015-08-13 | 2017-05-20 | Fluorouricil + Folonic Acid (MdG) | 2 | N | 10457624 | CARBOPLATIN + PEMETREXED |
| 10009234 | 10004651 | 1.56 | null | Palliative (P) | 2015-03-19 | 2015-05-28 | Capecitabine | 2 | null | 10465732 | CAPECITABINE |
| 10009235 | 10004664 | 1.55 | 78 | Palliative (P) | 2014-12-29 | 2014-12-29 | Carboplatin + Vinorelbine Oral | N | N | 10467268 | PEMETREXED |
| 10009236 | 10004697 | 1.76 | 67.8 | Palliative (P) | 2019-01-17 | 2019-04-11 | Temozolomide 150mg/m2 | N | N | 10470305 | TEMOZOLOMIDE |
| 10009237 | 10004709 | 1.7 | 80.3 | Palliative (P) | 2018-03-30 | 2019-03-28 | Carboplatin + Pemetrexed | 02 | N | 10472325 | PEMETREXED |
| 10009238 | 10007403 | 0 | 87.3 | Palliative (P) | 2017-09-07 | 2017-09-13 | CARBOPLATIN + PACLITAXEL | 2 | N | 10480034 | CARBOPLATIN + PACLITAXEL |
| 10009239 | 10004770 | 1.59 | 87.65 | Palliative (P) | 2018-04-18 | 2018-05-11 | BCG Intravesical | 02 | N | 10481342 | IBRUTINIB |
| 10009240 | 10004773 | 1.76 | 63.5 | Palliative (P) | 2017-10-22 | 2018-10-31 | GemCarbo Days 1+8 | 02 | N | 10481483 | GEMCARBO |
| 10009241 | 10007444 | 1.75 | 72.3 | Palliative (P) | 2019-03-03 | 2019-03-11 | CABOZANTINIB | 2 | N | 10487753 | CVD |
| 10009242 | 10007446 | 1.7 | 98 | Neo-adjuvant (N) | 2018-07-31 | 2019-03-20 | Cisplatin + Vinorelbine (PO) | N | null | 10487958 | CISPLATIN + RT |
| 10009243 | 10004925 | 1.68 | 71.1 | Palliative (P) | 2014-11-07 | 2014-11-07 | PMitCEBO-R | Y | N | 10496656 | CVD |
| 10009244 | 10004943 | 1.63 | null | null | 2018-08-12 | 2018-08-21 | Cisplatin +Fluorouracil (3 wk) | N | N | 10502066 | CHLORAMBUCIL + OBINUTUZUMAB |
| 10009245 | 10007501 | 1.71 | 61 | Palliative (P) | 2017-01-31 | 2017-06-13 | CRIZOTINIB | null | N | 10505533 | ECX |
| 10009246 | 10005005 | null | 84 | Palliative (P) | 2018-02-10 | 2018-02-10 | Gefitinib: Cycle 3 only (PAS) | 2 | N | 10508761 | TRIFLURIDINE + TIPIRACIL |
| 10009247 | 10005012 | 1.79 | 78.2 | Neo-adjuvant (N) | 2015-07-08 | 2015-07-12 | Methotrexate intrathecal | null | null | 10509197 | CISPLATIN + VINORELBINE + RT |
| 10009248 | 10005027 | 1.8 | 92.5 | Palliative (P) | 2016-01-14 | 2016-02-24 | Enzalutamide | 2 | null | 10510063 | CETUXIMAB |
| 10009249 | 10005054 | 1.99 | 56 | Palliative (P) | 2018-08-21 | 2018-09-08 | LEAM | 2 | N | 10514513 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE |
| 10009250 | 10005094 | 1.77 | 61 | Palliative (P) | 2020-03-11 | 2020-03-14 | EC | 1 | N | 10519170 | TRIFLURIDINE + TIPIRACIL |
| 10009251 | 10005117 | 1.48 | 78.1 | Palliative (P) | 2017-11-21 | 2018-04-12 | EC | N | 2 | 10522682 | ERLOTINIB |
| 10009252 | 10005178 | 1.71 | null | Curative (C) | 2019-01-10 | 2019-04-25 | Liposomal Doxorubicin 50mg/m2 | 2 | N | 10534514 | CAPECITABINE + CARBOPLATIN |
| 10009253 | 10005234 | null | 120 | Palliative (P) | null | 2020-01-26 | Brentuximab | 02 | N | 10541130 | IRINOTECAN |
| 10009254 | 10005260 | 1.7 | 68.4 | Palliative (P) | 2016-03-27 | 2016-03-27 | Liposomal Doxorubicin (Caelyx) | 02 | N | 10544316 | CETUXIMAB + OXALIPLATIN + MDG |
| 10009255 | 10005269 | 1.83 | null | Curative (C) | 2016-09-21 | 2017-02-16 | Cetuximab+Cisplatin+FU (> Cycle 2) | 02 | N | 10544598 | CAPECITABINE + CARBOPLATIN |
| 10009256 | 10005369 | 1.65 | 91.1 | Palliative (P) | 2018-04-11 | 2018-04-11 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 10557618 | ECX |
| 10009257 | 10005374 | null | 74.5 | Palliative (P) | 2016-09-08 | 2016-10-05 | CHLORAMBUCIL + RITUXIMAB | N | N | 10558140 | BUSULPHAN |
| 10009258 | 10005376 | 1.7 | 77.8 | Curative (C) | 2017-12-24 | 2018-08-07 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | N | N | 10558553 | DOCETAXEL + NINTEDANIB |
| 10009259 | 10005400 | 1.71 | 92.3 | Palliative (P) | 2019-08-27 | 2019-09-09 | AML18 PILOT TRIAL | 02 | N | 10562814 | CETUXIMAB + RT |
| 10009260 | 10005443 | null | 0 | Disease modification (D) | 2018-09-07 | 2019-06-01 | Bortezomib (weekly) | N | N | 10269868 | ECX |
| 10009261 | 10005523 | 1.76 | 68 | Palliative (P) | 2019-05-08 | 2019-05-09 | Melphalan IV High dose | 2 | N | 10430552 | CVD |
| 10009262 | 10005538 | 1.65 | 63 | Disease modification (D) | 2019-07-04 | 2020-07-04 | Hydroxycarbamide | N | N | 10445767 | DA |